Form 8-K - Current report:
SEC Accession No. 0001558370-24-009140
Filing Date
2024-06-13
Accepted
2024-06-13 16:30:13
Documents
14
Period of Report
2024-06-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K glyc-20240610x8k.htm   iXBRL 8-K 43791
  Complete submission text file 0001558370-24-009140.txt   182440

Data Files

Seq Description Document Type Size
2 EX-101.SCH glyc-20240610.xsd EX-101.SCH 3510
3 EX-101.LAB glyc-20240610_lab.xml EX-101.LAB 18759
4 EX-101.PRE glyc-20240610_pre.xml EX-101.PRE 13112
17 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20240610x8k_htm.xml XML 4658
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 241041660
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)